These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 11692510)
21. Production of veterinary vaccines in the Sudan. Babiker SH Berl Munch Tierarztl Wochenschr; 1996 Jan; 109(1):8-9. PubMed ID: 8593158 [TBL] [Abstract][Full Text] [Related]
22. [Improvement of veterinary vaccines through the use of new adjuvants]. Hilgers LA Tijdschr Diergeneeskd; 1991 May; 116(10):508-12. PubMed ID: 2048061 [TBL] [Abstract][Full Text] [Related]
23. Current status of veterinary vaccines. Meeusen EN; Walker J; Peters A; Pastoret PP; Jungersen G Clin Microbiol Rev; 2007 Jul; 20(3):489-510, table of contents. PubMed ID: 17630337 [TBL] [Abstract][Full Text] [Related]
24. Out on the farm with DNA vaccines. Beard CW; Mason PW Nat Biotechnol; 1998 Dec; 16(13):1325-8. PubMed ID: 9853612 [TBL] [Abstract][Full Text] [Related]
27. OIE standards for vaccines and future trends. Edwards S Rev Sci Tech; 2007 Aug; 26(2):373-8. PubMed ID: 17892158 [TBL] [Abstract][Full Text] [Related]
28. Regulatory considerations for marker vaccines and diagnostic tests in the U.S. Foley PL; Hill RE Biologicals; 2005 Dec; 33(4):253-6. PubMed ID: 16257538 [TBL] [Abstract][Full Text] [Related]
29. Recent Advances in Vaccine Technologies. Francis MJ Vet Clin North Am Small Anim Pract; 2018 Mar; 48(2):231-241. PubMed ID: 29217317 [TBL] [Abstract][Full Text] [Related]
30. [New technologies for vaccine development]. Leclerc C Med Sci (Paris); 2007 Apr; 23(4):386-90. PubMed ID: 17433228 [TBL] [Abstract][Full Text] [Related]
31. Some remarks on the efficacy of vaccines for veterinary use. Lensing HH Dev Biol Stand; 1992; 79():43-5. PubMed ID: 1286764 [No Abstract] [Full Text] [Related]
32. Technical requirements of veterinary vaccines for registration--FEDESA's point of view. Watson J Dev Biol Stand; 1992; 79():51-63. PubMed ID: 1286766 [No Abstract] [Full Text] [Related]
33. Challenges and opportunities in developing and marketing vaccines for OIE List A and emerging animal diseases. Gay CG; Salt J; Balaski C Dev Biol (Basel); 2003; 114():243-50. PubMed ID: 14677694 [TBL] [Abstract][Full Text] [Related]
34. Fish vaccine antigens produced or delivered by recombinant DNA technologies. Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855 [TBL] [Abstract][Full Text] [Related]
36. Vaccination in food animal populations. van Oirschot JT Vaccine; 1994 Apr; 12(5):415-8. PubMed ID: 8023549 [TBL] [Abstract][Full Text] [Related]
37. The application of nucleic acid vaccines in veterinary medicine. Dunham SP Res Vet Sci; 2002 Aug; 73(1):9-16. PubMed ID: 12208102 [TBL] [Abstract][Full Text] [Related]
38. [Possibilities and limitations in veterinary vaccine development using the example of classical swine fever]. Blome S; Gabriel C; Beer M Berl Munch Tierarztl Wochenschr; 2013; 126(11-12):481-90. PubMed ID: 24511823 [TBL] [Abstract][Full Text] [Related]
39. Biotechnology and DNA vaccines for aquatic animals. Kurath G Rev Sci Tech; 2008 Apr; 27(1):175-96. PubMed ID: 18666487 [TBL] [Abstract][Full Text] [Related]
40. Assuring the quality and safety of vaccines: regulatory licensing and batch release. Griffiths E; Knezevic I Methods Mol Med; 2003; 87():353-76. PubMed ID: 12958467 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]